Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

被引：0
作者：
James Yarmolinsky
Emmanouil Bouras
Andrei Constantinescu
Kimberley Burrows
Caroline J. Bull
Emma E. Vincent
Richard M. Martin
Olympia Dimopoulou
Sarah J. Lewis
Victor Moreno
Marijana Vujkovic
Kyong-Mi Chang
Benjamin F. Voight
Philip S. Tsao
Marc J. Gunter
Jochen Hampe
Andrew J. Pellatt
Paul D. P. Pharoah
Robert E. Schoen
Steven Gallinger
Mark A. Jenkins
Rish K. Pai
Dipender Gill
Kostas K. Tsilidis
机构：
[1] University of Bristol,MRC Integrative Epidemiology Unit
[2] Bristol Medical School,Population Health Sciences
[3] University of Bristol,Department of Hygiene and Epidemiology
[4] University of Ioannina Medical School,School of Translational Health Sciences
[5] University of Bristol,NIHR Bristol Biomedical Research Centre
[6] University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol,Biomarkers and Susceptibility Unit, Oncology Data Analytics Program
[7] Catalan Institute of Oncology (ICO),Colorectal Cancer Group, ONCOBELL Program
[8] L’Hospitalet de Llobregat,Department of Clinical Sciences, Faculty of Medicine
[9] Bellvitge Biomedical Research Institute (IDIBELL),Department of Medicine
[10] L’Hospitalet de Llobregat,Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine
[11] Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP),Department of Genetics
[12] University of Barcelona,Institute of Translational Medicine and Therapeutics
[13] Corporal Michael J. Crescenz VA Medical Center,Department of Medicine
[14] University of Pennsylvania Perelman School of Medicine,Stanford Cardiovascular Institute
[15] University of Pennsylvania,Nutrition and Metabolism Section, International Agency for Research on Cancer
[16] Perelman School of Medicine,Department of Medicine I
[17] University of Pennsylvania,Department of Public Health and Primary Care
[18] University of Pennsylvania,Department of Medicine and Epidemiology
[19] VA Palo Alto Epidemiology Research and Information Center for Genomics,Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
[20] VA Palo Alto Health Care System,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[21] Stanford University School of Medicine,Department of Laboratory Medicine and Pathology
[22] Stanford University School of Medicine,Department of Epidemiology and Biostatistics, School of Public Health
[23] World Health Organization,undefined
[24] University Hospital Dresden,undefined
[25] Technische Universität Dresden (TU Dresden),undefined
[26] University of Texas MD Anderson Cancer Center,undefined
[27] University of Cambridge,undefined
[28] University of Pittsburgh Medical Center,undefined
[29] University of Toronto,undefined
[30] The University of Melbourne,undefined
[31] Mayo Clinic Arizona,undefined
[32] Imperial College London,undefined
[33] St Mary’s Campus,undefined
来源：
Diabetologia | 2023年 / 66卷
关键词：
ABCC8; Breast cancer; Colorectal cancer; GLP1R; Glucose-lowering drug targets; Mendelian randomisation; PPARG; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1481 / 1500
页数：19
相关论文
共 165 条
  • [1] Khan MAB(2020)Epidemiology of type 2 diabetes - global burden of disease and forecasted trends J Epidemiol Glob Health 10 107-111
  • [2] Hashim MJ(2017)Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management Front Endocrinol (Lausanne) 8 6-30
  • [3] King JK(2017)Metformin targets multiple signaling pathways in cancer Chin J Cancer 36 17-81
  • [4] Govender RD(2007)Effects of thiazolidinediones on differentiation, proliferation, and apoptosis Mol Cancer Res 5 523-5
  • [5] Mustafa H(2018)Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis Saudi J Gastroenterol 24 75-905
  • [6] Al Kaabi J(2016)Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer Proc Natl Acad Sci U S A 113 8290-72
  • [7] Chaudhury A(2012)Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes Breast Cancer Res 14 R8-61
  • [8] Duvoor C(1995)Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin J Clin Invest 95 1897-905
  • [9] Reddy Dendi VS(2011)Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells Endocrinology 152 3362-12
  • [10] Lei Y(2012)The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells Breast Cancer Res Treat 132 449-61
12345678910